Targeting programmed cell death ligand 1 by CRISPR/Cas9 in osteosarcoma cells

Programmed cell death ligand 1 (PD-L1) is a transmembrane protein that is expressed on tumor cells that suppresses the T cell-mediated immune response. Therapies targeting the PD-L1 pathway promote anti-tumor immunity and have shown promising results in some types of cancers. However, the functional...

Descripción completa

Detalles Bibliográficos
Autores principales: Liao, Yunfei, Chen, Lulu, Feng, Yong, Shen, Jacson, Gao, Yan, Cote, Gregory, Choy, Edwin, Harmon, David, Mankin, Henry, Hornicek, Francis, Duan, Zhenfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444742/
https://www.ncbi.nlm.nih.gov/pubmed/28415820
http://dx.doi.org/10.18632/oncotarget.16326

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444742/
https://www.ncbi.nlm.nih.gov/pubmed/28415820
http://dx.doi.org/10.18632/oncotarget.16326

Ejemplares similares